Tenascin-C protein expression and mRNA splice variants in thyroid carcinoma

Experimental and Molecular Pathology

Volumn 80, Issue 2, 2006, Pages 177-182

  Tseleni Balafouta, S ^a   Gakiopoulou, H ^a   Fanourakis, G ^a   Voutsinas, G ^b   Balafoutas, D ^a   Patsouris, E ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

Splice variants; Tenascin C; Thyroid carcinomas

Indexed keywords

MESSENGER RNA; MONOCLONAL ANTIBODY; TENASCIN;

ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER CELL; CELL ADHESION; CELL CULTURE; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; FEMALE; FOLLICULAR CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDULLARY CARCINOMA; ONCOCYTOMA; PAPILLARY CARCINOMA; PREVALENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; STROMA; THYROID CANCER; THYROID CARCINOMA; THYROID MEDULLARY CARCINOMA; TISSUE DISTRIBUTION;

EID: 33644542091     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2005.09.006     Document Type: Article

References (42)

1. M. Adams, J.L. Jones, R.A. Walker, J.H. Pringle, and S.C. Bell Changes in tenascin-C isoform expression in invasive and preinvasive breast disease Cancer Res. 62 2002 3289 3297
2. S. Aishima, K. Taguchi, T. Terashi, S. Matsuura, M. Shimada, and M. Tsuneyoshi Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma Mod. Pathol. 16 2003 1019 1027
3. W. Back, C. Heubner, J. Winter, and U. Bleyl Expression of tenascin in lymphocytic autoimmune thyroiditis J. Clin. Pathol. 50 1997 863 866
4. L. Borsi, B. Carnemolla, G. Nicolo, B. Spina, G. Tanara, and L. Zardi Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissue Int. J. Cancer 52 1992 688 692
5. A. Brunner, C. Mayerl, A. Tzankov, I. Verdorfer, I. Tschorner, H. Rogatsch, and G. Mikuz Prognostic significance of tenascin-C expression in superficial and invasive bladder cancer J. Clin. Pathol. 57 2004 927 931
6. R. Chiquet-Ehrismann Tenascins Int. J. Biochem. Cell Biol. 36 2004 986 990
7. R. Chiquet-Ehrismann, and M. Chiquet Tenascins: regulation and putative functions during pathological stress J. Pathol. 200 2003 488 499
8. R. Chiquet-Ehrismann, and R.P. Tucker Connective tissues: signaling by tenascins Int. J. Biochem. Biol. 36 2004 1085 1089
9. R. Chiquet-Ehrismann, Y. Matsuoka, U. Hofer, J. Spring, C. Bernasconi, and M. Chiquet Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues Cell Regul. 2 1991 927 938
10. M. Dueck, S. Riedl, U. Hinz, A. Tandara, P. Moller, C. Herfarth, and A. Faissner Detection of tenascin-C isoforms in colorectal mucosa, ulcerative colitis and liver metastases Int. J. Cancer 82 1999 477 483
11. P. Ekbolm, and E. Aufderheide Stimulation of tenascin expression in mesenchyme by epithelial-mesenchymal interactions Int. J. Dev. Biol. 33 1989 71 79
12. H.P. Erickson Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions Curr. Opin. Cell Biol. 7 1993 869 876
13. M.A. Ghert, S.T. Jung, W. Qi, J.M. Harrelson, H.P. Erickson, J.A. Block, and S.P. Scully The clinical significance of tenascin-C splice variant expression in chondrosarcomas Oncology 61 2001 306 314
14. S. Hauptmann, L. Zardi, A. Siri, B. Carnemolla, L. Borsi, M. Castellucci, B. Klosterhalfen, P. Hartung, J. Weis, and G. Stocker Extracellular matrix proteins in colorectal carcinomas. Expression of tenascin and fibronectin isoforms Lab. Invest. 73 1995 172 182
15. C. Herold-Mende, M.M. Bonsanto, A. Buttler, S. Kunze, and H.H. Steiner Expression of tenascin splice variants in gliomas Jahrestagung der Deutschen Gesellschaft für Neurochirurgie vol. 50 1999 Springer Munich Meeting Abstract No. 503
16. W. Hindermann, A. Berndt, L. Borsi, X. Luo, P. Hyckel, D. Katenkamp, and H. Kosmehl Synthesis and distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma J. Pathol. 189 1999 475 480
17. Y. Ikeda, M. Mori, K. Kajiyama, Y. Haraguchi, O. Sasaki, and K. Sugimachi Immunohistochemical expression of tenascin in normal stomach tissue, gastric carcinoma and gastric carcinoma in lymph nodes Br. J. Cancer 72 1995 189 192
18. K. Imanaka-Yoshida, M. Hiroe, Y. Yasutomi, T. Toyozaki, T. Tsuchiya, N. Noda, T. Maki, T. Nishikawa, T. Sakakura, and T. Yoshida Tenascin-C is a useful marker for disease activity in myocarditis J. Pathol. 197 2002 388 394
19. E. Ioachim, A. Charchanti, E. Briasoulis, V. Karavasilis, H. Tsanou, D.L. Arvanitis, N.J. Agnantis, and N. Pavlidis Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression Eur. J. Cancer 38 2002 2362 2370
20. A. Ishihara, T. Yoshida, H. Tamaki, and T. Sakakura Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance Clin. Cancer Res. 1 1995 1035 1041
21. T. Jahkola, T. Toivonen, K. von Smitten, C. Blomqvist, and I. Virtanen Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis Int. J. Cancer 69 1996 445 447
22. T. Jahkola, T. Toivonen, I. Virtanen, K. von Smitten, S. Nordling, K. von Boguslawski, C. Haglund, H. Nevanlinna, and C. Blomqvist Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence Br. J. Cancer 78 1998 1507 1513
23. K. Katenkamp, A. Berndt, W. Hindermannn, H. Wunderlich, K.M. Haas, L. Borsi, L. Zardi, and H. Kosmehi mRNA expression and protein distribution of the unspliced tenascin-C isoform in prostatic adenocarcinoma J. Pathol. 203 2004 771 779
24. G.K. Koukoulis, C. Patriarca, and V.E. Gould Adhesion molecules and tumor metastasis Hum. Pathol. 29 1998 889 892
25. G.K. Koukoulis, A.K. Koso-Thomas, L. Zardi, G. Gabbiani, and V.E. Gould Enhanced tenascin expression correlates with inflammation in primary sclerosing cholangitis Pathol. Res. Pract. 195 1999 727 731
26. H. Kusagawa, K. Onoda, S. Namikawa, I. Yada, A. Okada, T. Yoshida, and T. Sakakura Expression and degeneration of tenascin-C in human lung cancer Br. J. Cancer 77 1998 98 102
27. J. Lohi, T. Tani, L. Laitinen, L. Kangas, V.-P. Lehto, and I. Virtanen Tenascin and fibronectin isoforms in human renal cell carcinomas, renal cell carcinoma cell lines and xenografts in nude mice Int. J. Cancer 63 1995 442 449
28. E.J. Mackie, R. Chiquet-Ehrismann, C.A. Pearson, Y. Inaguma, K. Taya, Y. Kawarada, and T. Sakatura Tenascin is a stromal marker for epithelial malignancy in the mammary gland Proc. Natl. Acad. Sci. U. S. A. 84 1987 4621 4625
29. T. Masaki, N. Yorioka, Y. Taniguchi, H. Oda, and M. Yamakido Tenascin expression may reflect the activity and chronicity of human IgA nephropathy Clin. Nephrol. 50 1998 205 213
30. H. Moch, J. Torhorst, U. Durmuller, G.E. Feichter, G. Sauter, and F. Gudat Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer Pathol. Res. Pract. 189 1993 510 514
31. J.E. Murphy-Ullrich The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J. Clin. Invest. 7 2001 785 790
32. C.A. Pearson, D. Pearson, S. Shibahara, J. Hofsteenge, and R. Chiquet-Ehrismann Tenascin: cDNA cloning and induction by TGF-β EMBO J. 7 1988 2977 2981
33. H. Pilch, U. Schäffer, K. Schlenger, A. Lautz, B. Tanner, M. Höckel, and P.G. Knapstein Expression of tenascin in human cervical cancer-Association of tenascin expression with clinico-pathological parameters Gynecol. Oncol. 73 1999 415 421
34. L. Puiu, E. Petrakou, A. Apostolidou, A. Athanassiadou, L. Psiouri, A. Papachatzopoulou, V.G. Gorgoulis, A. Kotsinas, E. Tzoracoeleftherakis, G.M. Maniatis, and G. Voutsinas Lack of Fas (APO/CD95) gene structural alterations on transcript variant ratio changes in breast cancer Cancer Lett. 194 2003 91 97
35. C.R. Ruegg, R. Chiquet-Ehrismann, and S.S. Alkan Tenascin, an extracellular matrix protein, exerts immunomodulatory activities Proc. Natl. Acad. Sci. U. S. A. 86 1989 7437 7441
36. T. Sakai, H. Kawakatsu, N. Hirota, T. Yokoyama, and T. Sakakura Specific expression of tenascin in human colonic neoplasms Br. J. Cancer 67 1993 1059 1064
37. T. Sakakura, and M. Kusakabe Can tenascin be redundant in cancer development? Perspect. Dev. Neurobiol. 2 1994 111 116
38. T. Shoji, T. Kamiya, A. Tsubura, Y. Hamada, T. Hatano, K. Hioki, and S. Morii Tenascin staining positivity and the survival of patients with invasive breast carcinomas J. Surg. Res. 55 1993 295 297
39. Y. Soini, P. Paako, K. Nuorva, D. Kamel, A. Linnala, I. Virtanen, and V.P. Lehto Tenascin immunoreactivity in lung tumors Am. J. Clin. Pathol. 100 1993 145 150
40. O. Tiita, T. Wahlström, J. Paavonen, A. Linnala, S. Sharma, V.E. Gould, and I. Virtanen Enhanced tenascin expression in cervical and koilocytotic lesions Am. J. Pathol. 141 1992 907 912
41. T. Tsunoda, H. Inada, H. Kalembeyi, K. Imanaka-Yoshida, M. Sakakibara, R. Okada, K. Katsuta, T. Sakakura, Y. Majima, and T. Yoshida Involvement of large tenascin-C splice variants in breast cancer progression Am. J. Pathol. 162 2003 1857 1867
42. T. Yoshida, E. Yoshimura, H. Numata, Y. Sakakura, and T. Sakakura Involvement of tenascin-C in proliferation and migration of laryngeal carcinoma cells Virchows Arch. 435 1999 496 500